FVD
First Trust Value Line Dividend Index Fund · PSE
- Category High Dividend Yield
- Expense Ratio 0.6%
- Listing Date Dec 18, 2006
- Volume 639,009.0
- Market Cap (AUM) $9,841.25M
Performance
+1.12%
1W
+6.23%
1M
+5.06%
3M
+11.57%
6M
+5.08%
YTD
+8.94%
1Y
Top Holdings
-
Name
Symbol%Assets
- Garmin Ltd.GRMN0.65%
- J & J Snack Foods Corp.JJSF0.65%
- Texas Instruments IncorporatedTXN0.64%
- Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADRTSM0.63%
- C.H. Robinson Worldwide, Inc.CHRW0.63%
- California Water Service GroupCWT0.63%
- NextEra Energy, Inc.NEE0.63%
- Amgen Inc.AMGN0.62%
- Analog Devices, Inc.ADI0.62%
- Watsco, Inc.WSO0.62%
Technical Analysis of FVD 2024-05-10
Overview:
In analyzing the technical indicators for FVD over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for informed decision...
Recent News & Updates
- 2018-01-11 21:33
Why Assurant Has a Positive Outlook despite a Weak 2017(Marketrealist)
- 2017-11-14 20:01
Behind Novartiss Respiratory Drug Performance in 3Q17(Marketrealist)
- 2017-11-02 20:57
An ETF For Dividend Achievers(Yahoo Finance)
- 2017-10-30 04:55
- 2017-10-18 21:46
How Do Aerospace and Defense Sector Dividends Look?(Marketrealist)
- 2017-09-20 05:29
- 2017-09-19 23:09
What Led to Sempra Energys Sharp Fall in Dividend Yield?(Marketrealist)
- 2017-09-19 19:38
- 2017-09-18 02:19
What Analysts Recommend for Novartis in September 2017(Marketrealist)
- 2017-09-11 00:32
What Could Drive TechnipFMCs Dividend Yield(Marketrealist)
- 2017-08-31 00:34
GlaxoSmithKline Reported Revenue Growth in 2Q17(Marketrealist)
- 2017-08-30 04:36
Inside Novartiss 2Q17 Revenues(Marketrealist)
- 2017-08-29 01:12
Bristol-Myers Squibbs Valuation after 2Q17 Earnings(Marketrealist)
- 2017-08-23 00:42
Dividend Yield of Franklin Resources(Marketrealist)
- 2017-08-17 21:07
Sanofis General Medicines and Consumer Healthcare in 2Q17(Marketrealist)
- 2017-08-16 04:44
A Look at Sanofis Post-2Q17 Valuation(Marketrealist)
- 2017-08-15 23:06
Target s Performance as a Dividend Aristocrat(Marketrealist)
- 2017-08-08 19:40
- 2017-07-31 21:10
GSKs 2Q17 Earnings: Pharmaceuticals Segment(Marketrealist)
- 2017-07-26 00:09
Arbor Realty Trusts Dividend Growth Prospects(Marketrealist)
- 2017-07-25 06:06
Unpacking GlaxoSmithKlines 2Q17 Revenue Expectations(Marketrealist)
- 2017-07-24 02:35
Novartis in 2Q17: Performance of Innovative Medicines(Marketrealist)
- 2017-07-17 01:35
Novartiss 2Q17 Estimates: Innovative Medicines Segment(Marketrealist)
- 2017-07-12 02:44
The Top Dividend-Growing Healthcare and Industrials Stocks(Marketrealist)
- 2017-07-06 23:49
Dividend Growth for Qualcomm and Crown Castle International(Marketrealist)
- 2017-06-25 21:35
First Trust Introduces A Slew Of New ETFs(Yahoo Finance)
- 2017-06-21 04:30
- 2017-06-13 21:57
Dividend ETFs Are Hot on Likely Dovish Fed Outlook(Yahoo Finance)
- 2017-05-31 19:38
What Happened to Novartiss Valuation after 1Q17?(Marketrealist)
- 2017-05-28 22:36
Sanofis Generics and Consumer Healthcare Business in 1Q17(Marketrealist)
- 2017-04-21 04:35
Novartiss 1Q17 Estimates: Innovative Medicines Segment(Marketrealist)
- 2017-04-03 19:36
Could Novartiss CTL019 Capture Significant Market Share?(Marketrealist)
- 2017-04-03 19:36
- 2017-04-02 22:40
Are Sanofis Established Prescription Products Adding Up?(Marketrealist)
- 2017-04-02 21:06
Novartis Expects to Witness Flat Revenue Growth in 2017(Marketrealist)
- 2017-03-31 05:06
Inside Sanofis Overall Revenue Performance in 2016(Marketrealist)
- 2017-03-29 19:36
- 2017-03-24 03:07
Novartiss Valuation Compared to Its Peers(Marketrealist)
- 2017-03-22 05:25
- 2017-03-21 19:38
What Will Drive AstraZenecas Oncology Revenues in 2017?(Marketrealist)